vi
Chapter 20
Mahdis Dorkalam, MSc, RHN
President
Canada
Navneet Sekhon
President
AxSource Consulting Inc.
Canada
Chapter 21
Loes Pelgrim, MSc
Clinical Consultant, Owner
Pelgrim Clinical
Netherlands
Gert Bos, MSc, PhD, FRAPS
Chief Scientific Officer, Executive
Director, and Partner
Qserve Group
Netherlands
Chapter 22
Monique Carter, MS, RAC
Senior Director, Global Regulatory
Affairs
Pfizer, Inc.
US
Samantha Zappia, MS, RAC
Principal Consultant
US
Chapter 23
David W. Husman, PhD, ASQ
CPGP, RAC
President and Principal Consultant
David Husman Consulting, LLC
US
John Rossman, MBEE, RAC
Senior Manager, Regulatory Affairs
Stryker
US
Chapter 24
Robert Rogers, MS, RAC
Associate Director, Regulatory
Affairs
Qiagen
US
Chapters 25, 26, and 27
Edward Tabor, MD
George Washington University
School of Medicine and Health
Sciences
US
Chapter 28
Salma Michor, PhD, MBA,
CMgr, CQA, RAC
CEO and Principal Consultant
Michor Consulting and Trade
Services GmbH
Austria
Chapter 20
Mahdis Dorkalam, MSc, RHN
President
Canada
Navneet Sekhon
President
AxSource Consulting Inc.
Canada
Chapter 21
Loes Pelgrim, MSc
Clinical Consultant, Owner
Pelgrim Clinical
Netherlands
Gert Bos, MSc, PhD, FRAPS
Chief Scientific Officer, Executive
Director, and Partner
Qserve Group
Netherlands
Chapter 22
Monique Carter, MS, RAC
Senior Director, Global Regulatory
Affairs
Pfizer, Inc.
US
Samantha Zappia, MS, RAC
Principal Consultant
US
Chapter 23
David W. Husman, PhD, ASQ
CPGP, RAC
President and Principal Consultant
David Husman Consulting, LLC
US
John Rossman, MBEE, RAC
Senior Manager, Regulatory Affairs
Stryker
US
Chapter 24
Robert Rogers, MS, RAC
Associate Director, Regulatory
Affairs
Qiagen
US
Chapters 25, 26, and 27
Edward Tabor, MD
George Washington University
School of Medicine and Health
Sciences
US
Chapter 28
Salma Michor, PhD, MBA,
CMgr, CQA, RAC
CEO and Principal Consultant
Michor Consulting and Trade
Services GmbH
Austria